-+ 0.00%
-+ 0.00%
-+ 0.00%

Emergent BioSolutions Affirms FY2026 Sales Guidance of $720.000M-$760.000M vs $735.000M Est

Benzinga·04/30/2026 20:32:42
Listen to the news
Emergent BioSolutions (NYSE:EBS) affirms FY2026 sales outlook from $720.000 million-$760.000 million to $720.000 million-$760.000 million vs $735.000 million estimate.